查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526935

2024 年診斷放射性同位素全球市場報告

Diagnostic Radioisotopes Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

診斷放射性同位素市場規模預計在未來幾年將強勁成長。 2028年，將以9.8%的複合年成長率成長至80.6億美元。預計期間的成長是由放射性同位素生產的新方法、擴大臨床應用範圍、轉向以患者為中心的護理和安全、擴大採用即時成像、環境永續性以及對綠色化學的重視所推動的。這段時期預計的主要趨勢包括混合成像方法、治療診斷學的進步、分子成像技術的進步、迴旋加速器或發生器的利用以及對安全和輻射防護的持續關注。

隨著癌症患者數量的增加，診斷放射性同位素市場預計也會成長。癌症的特徵是異常、不受控制的細胞分裂，導致組織損傷，由多種因素引起，包括吸煙、肥胖、缺乏運動、接觸致癌物質、遺傳傾向和環境影響等生活方式選擇。放射性同位素在癌症管理中發揮重要作用，有助於準確診斷、有針對性的治療以及有效監測疾病進展和治療反應。例如，根據歐盟委員會2023年10月發布的報告，新癌症患者將比2020年增加2.3%，2022年達到274萬，癌症相關死亡人數也將相應增加2.4%。這一趨勢凸顯了癌症負擔的日益增加，並推動了對診斷放射性同位素的需求。

診斷放射性同位素市場的主要企業致力於推進放射性製藥技術，以提高診斷準確性、改善患者治療效果並擴大核醫學在醫療保健中的應用。先進的放射性製藥技術包括開發用於核醫學精確成像和標靶治療的創新化合物和技術。例如，義大利診斷影像公司Bracco Group於2022年3月推出了Blue Earth Therapeutics，這是一家專門開發下一代治療放射性藥物技術的子公司，最初針對前列腺癌，並計劃進一步擴展到其他癌症領域。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球診斷放射性同位素市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球診斷放射性同位素市場表現：規模與成長，2018-2023
  • 全球診斷放射性同位素市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球診斷放射性同位素市場：放射性同位素的表現與預測，2018-2023、2023-2028、2033
  • Technetium99m
  • 鉈201
  • 鎵67
  • 碘123
  • 氟脫氧葡萄糖 (FDG)
  • 銣82
  • 其他放射性同位素
  • 全球診斷放射性同位素市場：依影像方式分類的表現與預測，2018-2023、2023-2028、2033
  • 單光子發射電腦斷層掃描 (SPECT)
  • 正子斷層掃描 (PET)
  • BETA放射體
  • 全球診斷放射性同位素市場：依應用、實際及預測分類，2018-2023、2023-2028、2033
  • 腫瘤學
  • 心臟病學
  • 其他用途
  • 全球診斷放射性同位素市場：按最終用戶、實際和預測，2018-2023、2023-2028、2033
  • 醫院
  • 專科診所
  • 診斷中心
  • 學術研究所
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球診斷放射性同位素市場：按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球診斷放射性同位素市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 診斷放射性同位素市場：競爭格局
  • 診斷放射性同位素市場：公司簡介
    • Cardinal Health Inc.
    • Sumitomo Heavy Industries Ltd.
    • BWX Technologies Inc.
    • Lantheus Holdings
    • Curium Pharma

第31章 其他大型創新企業

  • Clarity Pharmaceuticals
  • Bracco Diagnostic Inc.
  • Ion Beam Applications SA
  • Nordion Inc.
  • Eckert & Ziegler AG
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes SOC Ltd
  • Global Medical Solutions Ltd.
  • Isotopia Molecular Imaging Ltd.
  • Cyclopharm Limited
  • Trasis NV
  • Orano Med LLC
  • ARTMS Inc.
  • Radiomedix Inc.
  • Coqu RadioPharmaceuticals Corp.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18584

Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.

The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.

The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic radioisotopes market size has grown strongly in recent years. It will grow from $5.06 billion in 2023 to $5.54 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The increase in the historical era can be credited to several factors, including the identification of radioactivity, the advent of technetium-99m, advancements in clinical applications and research, developments during the Cold War and in nuclear research, and the rise of positron emission tomography.

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.06 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The projected period growth can be attributed to emerging methods for radioisotope production, the broadening scope of clinical applications, a shift towards patient-centered care and safety, the growing prevalence of point-of-care imaging, and a focus on environmental sustainability and green chemistry. Key trends anticipated in this period encompass hybrid imaging approaches, the advancement of theranostics, the evolution of molecular imaging techniques, the utilization of cyclotrons or generators, and ongoing efforts in safety and radiation protection.

The anticipated rise in cancer cases is expected to drive the growth of the diagnostic radioisotopes market. Cancer, characterized by the uncontrolled division of abnormal cells leading to tissue damage, is attributed to various factors including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic predisposition, and environmental influences. Radioisotopes play a crucial role in cancer management, facilitating precise diagnosis, targeted treatment, and effective monitoring of disease progression or response to therapy. For instance, according to a report by the European Commission in October 2023, new cancer cases increased by 2.3% from 2020, reaching 2.74 million in 2022, with a corresponding 2.4% increase in cancer-related deaths. This trend underscores the growing burden of cancer, thereby propelling the demand for diagnostic radioisotopes.

Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

North America was the largest region in the diagnostic radioisotopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Radioisotopes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
  • 2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
  • 3) By Application: Oncology; Cardiology; Other Applications
  • 4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users
  • Companies Mentioned: Cardinal Health Inc.; Sumitomo Heavy Industries Ltd.; BWX Technologies Inc.; Lantheus Holdings; Curium Pharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostic Radioisotopes Market Characteristics

3. Diagnostic Radioisotopes Market Trends And Strategies

4. Diagnostic Radioisotopes Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Diagnostic Radioisotopes Market Size and Growth

  • 5.1. Global Diagnostic Radioisotopes Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diagnostic Radioisotopes Market Segmentation

  • 6.1. Global Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FluoroDeoxyGlucose (FDG)
  • Rubidium-82
  • Other Radioisotopes
  • 6.2. Global Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Photon Emission Computed Tomography (SPECT)
  • Positron Emission Tomography (PET)
  • Beta Emitters
  • 6.3. Global Diagnostic Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Other Applications
  • 6.4. Global Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic And Research Institutes
  • Other End Users

7. Diagnostic Radioisotopes Market Regional And Country Analysis

  • 7.1. Global Diagnostic Radioisotopes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Diagnostic Radioisotopes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diagnostic Radioisotopes Market

  • 8.1. Asia-Pacific Diagnostic Radioisotopes Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diagnostic Radioisotopes Market

  • 9.1. China Diagnostic Radioisotopes Market Overview
  • 9.2. China Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diagnostic Radioisotopes Market

  • 10.1. India Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diagnostic Radioisotopes Market

  • 11.1. Japan Diagnostic Radioisotopes Market Overview
  • 11.2. Japan Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diagnostic Radioisotopes Market

  • 12.1. Australia Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diagnostic Radioisotopes Market

  • 13.1. Indonesia Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diagnostic Radioisotopes Market

  • 14.1. South Korea Diagnostic Radioisotopes Market Overview
  • 14.2. South Korea Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diagnostic Radioisotopes Market

  • 15.1. Western Europe Diagnostic Radioisotopes Market Overview
  • 15.2. Western Europe Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diagnostic Radioisotopes Market

  • 16.1. UK Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diagnostic Radioisotopes Market

  • 17.1. Germany Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diagnostic Radioisotopes Market

  • 18.1. France Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diagnostic Radioisotopes Market

  • 19.1. Italy Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diagnostic Radioisotopes Market

  • 20.1. Spain Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diagnostic Radioisotopes Market

  • 21.1. Eastern Europe Diagnostic Radioisotopes Market Overview
  • 21.2. Eastern Europe Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diagnostic Radioisotopes Market

  • 22.1. Russia Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diagnostic Radioisotopes Market

  • 23.1. North America Diagnostic Radioisotopes Market Overview
  • 23.2. North America Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diagnostic Radioisotopes Market

  • 24.1. USA Diagnostic Radioisotopes Market Overview
  • 24.2. USA Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diagnostic Radioisotopes Market

  • 25.1. Canada Diagnostic Radioisotopes Market Overview
  • 25.2. Canada Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diagnostic Radioisotopes Market

  • 26.1. South America Diagnostic Radioisotopes Market Overview
  • 26.2. South America Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diagnostic Radioisotopes Market

  • 27.1. Brazil Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diagnostic Radioisotopes Market

  • 28.1. Middle East Diagnostic Radioisotopes Market Overview
  • 28.2. Middle East Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diagnostic Radioisotopes Market

  • 29.1. Africa Diagnostic Radioisotopes Market Overview
  • 29.2. Africa Diagnostic Radioisotopes Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Diagnostic Radioisotopes Market, Segmentation By Imaging Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Diagnostic Radioisotopes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diagnostic Radioisotopes Market Competitive Landscape And Company Profiles

  • 30.1. Diagnostic Radioisotopes Market Competitive Landscape
  • 30.2. Diagnostic Radioisotopes Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sumitomo Heavy Industries Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. BWX Technologies Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lantheus Holdings
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Curium Pharma
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Diagnostic Radioisotopes Market Other Major And Innovative Companies

  • 31.1. Clarity Pharmaceuticals
  • 31.2. Bracco Diagnostic Inc.
  • 31.3. Ion Beam Applications S.A.
  • 31.4. Nordion Inc.
  • 31.5. Eckert & Ziegler AG
  • 31.6. NorthStar Medical Radioisotopes LLC
  • 31.7. NTP Radioisotopes SOC Ltd
  • 31.8. Global Medical Solutions Ltd.
  • 31.9. Isotopia Molecular Imaging Ltd.
  • 31.10. Cyclopharm Limited
  • 31.11. Trasis NV
  • 31.12. Orano Med LLC
  • 31.13. ARTMS Inc.
  • 31.14. Radiomedix Inc.
  • 31.15. Coqu RadioPharmaceuticals Corp.

32. Global Diagnostic Radioisotopes Market Competitive Benchmarking

33. Global Diagnostic Radioisotopes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Diagnostic Radioisotopes Market

35. Diagnostic Radioisotopes Market Future Outlook and Potential Analysis

  • 35.1 Diagnostic Radioisotopes Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Diagnostic Radioisotopes Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Diagnostic Radioisotopes Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer